Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FCE 22250

Known as: FCE-22250, Rifamycin, 3-(methyl(1-piperidinylmethylene)hydrazino)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
  • Shin Kawahara
  • Nihon rinsho. Japanese journal of clinical…
  • 1998
  • Corpus ID: 26549278
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to… Expand
Is this relevant?
1991
1991
After rats being given ig FCE 22250 5, 10 and 25 mg.kg-1, the plasma peak times (Tmax) were 12-14 h, the max plasma… Expand
Is this relevant?
1987
1987
The bactericidal activity of six new rifamycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP 29861 (C29… Expand
Is this relevant?
1985
1985
FCE 22250 (3-(N-piperidinomethylazino)methylrifamycin SV) is a member of the new class of 3-azinomethylrifamycins characterized… Expand
Is this relevant?